Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

KALLYA 1,5 MG COMPRIMIDO - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/KALLYA 1,5 MG COMPRIMIDO

Approved

STANDARD

KALLYA 1,5 MG COMPRIMIDO

Apotheke Laboratorios S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 23, 2024
Approval ID: 671eeae6374a95d9
Company: Apotheke Laboratorios S.L.
Type: Standard

Approval Details

Approval Id: 671eeae6374a95d9
Drug Cima Aemps Name: KALLYA 1,5 MG COMPRIMIDO
Register Number: 89381
Holder Company Name: Apotheke Laboratorios S.L.
Marketing Company Name: Apotheke Laboratorios S.L.
Authorization Date: 2024-02-23
Dosage Form: COMPRIMIDO
Dose: 1,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Apotheke Laboratorios S.L.

Active Ingredients

LEVONORGESTREL

1,5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 23, 2024

Approval ID

671eeae6374a95d9

Type

Standard

Back to CIMA-AEMPS Approvals